What dietary principles should be followed during upatinib treatment?
Upadatinib, a highly efficient and selective Janus kinase (JAK) inhibitor, has shown remarkable results in the treatment of various autoimmune diseases such as rheumatoid arthritis and atopic dermatitis. However, in order to ensure the efficacy of drugs and the safety of patients, in addition to correct medication, reasonable dietary habits are also crucial. In particular, certain foods may interact with upadatinib, thereby affecting the metabolism and effect of the drug in the body.
Among them, grapefruit is a food that requires special vigilance. Although grapefruit is rich in nutrients, the furanocoumarins contained in it may interfere with the activity of drug-metabolizing enzymes, causing the metabolism of upadatinib in the body to slow down and the blood drug concentration to increase abnormally. This change may increase the probability that patients will experience side effects such as gastrointestinal discomfort and increased risk of infection. Therefore, during upatinib treatment, patients should strictly avoid consuming grapefruit and all related products, including grapefruit juice, grapefruit jam, etc., to reduce potential risks.
In addition to grapefruit, patients should also pay attention to the balance and diversity of their diet. It is recommended to increase the intake of foods rich in protein, vitamins and minerals. These nutrients can help improve the body's immunity and provide strong support for the best effect of the medicine. At the same time, patients should try to avoid excessive drinking and smoking. These bad lifestyle habits may weaken the efficacy of the medication and even increase the risks of medication.
To sum up, during upatinib treatment, patients need to pay special attention to dietary arrangements and follow scientific dietary principles. By avoiding foods that may affect drug metabolism, such as grapefruit, maintaining a balanced diet, and abandoning bad lifestyle habits, patients can better ensure the efficacy of the drug and their own safety.
References:
https://www.drugs.com/rinvoq.html
xa0
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)